Urokinase Plasminogen Activator Induces Angiogenesis and Tumor Vessel Invasion in Breast Cancer

This publication has 15 references indexed in Scilit:

• Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer
  Breast Cancer Research and Treatment, 1993
• Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
  The Lancet, 1992
• Effective activation of the proenzyme form of the urokinase‐type plasminogen activator (pro‐uPA) by the cysteine protease cathepsin L
  FEBS Letters, 1992
• Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer
  Fibrinolysis, 1990
• Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas
  Cancer, 1989
• UROKINASE-TYPE PLASMINOGEN ACTIVATOR ANTIGEN AND EARLY RELAPSE IN BREAST CANCER
  The Lancet, 1989
• Plasminogen activator content of gynecological tumors and their metastases
  Gynecologic Oncology, 1987
• Plasminogen Activators, Tissue Degradation, and Cancer
  Published by Elsevier ,1985
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
  Journal of Histochemistry & Cytochemistry, 1984
• Immunohistochemical Identification of Factor VIII-Related Antigen in Endothelial Cells of Cutaneous Lesions of Alleged Vascular Nature
  American Journal of Clinical Pathology, 1981